Compare SFHG & ADXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SFHG | ADXN |
|---|---|---|
| Founded | 1993 | 2002 |
| Country | Hong Kong | Switzerland |
| Employees | N/A | N/A |
| Industry | Publishing | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.6M | 10.0M |
| IPO Year | 2024 | N/A |
| Metric | SFHG | ADXN |
|---|---|---|
| Price | $0.69 | $8.10 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 631.5K | 8.1K |
| Earning Date | 10-30-2025 | 12-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $19,577,200.00 | $198,824.00 |
| Revenue This Year | N/A | $86.57 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 3.56 | N/A |
| 52 Week Low | $0.32 | $6.51 |
| 52 Week High | $2.32 | $12.05 |
| Indicator | SFHG | ADXN |
|---|---|---|
| Relative Strength Index (RSI) | 73.53 | 47.77 |
| Support Level | $0.55 | $7.12 |
| Resistance Level | $0.59 | $8.49 |
| Average True Range (ATR) | 0.06 | 0.58 |
| MACD | 0.03 | 0.01 |
| Stochastic Oscillator | 91.79 | 52.40 |
Samfine Creation Holdings Group Ltd operates through its subsidiaries. It is an established one-stop printing service provider which principally provides printing services in Hong Kong and the PRC. It offers a wide range of printed products such as (i) book products, which mainly include children's books, educational books, art books, notebooks, diaries and journals; and (ii) novelty and packaging products, which mainly include handcraft products, book sets, pop-up books, stationery products, products with assembly parts and other specialized products, shopping bags and package boxes.
Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment, which is the discovery, development, and commercialization of small-molecule pharmaceutical products.